{"recordsFiltered":48703,"recordsTotal":48703,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=status&start=47700","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=status&start=47100","results":[{"registry_id":"NCT06395402","publication_url":"https://clinicaltrials.gov/study/NCT06395402","title":"177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry","has_exemption":false,"start_date":"2024-05-03","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06215469","publication_url":"https://clinicaltrials.gov/study/NCT06215469","title":"Amma™ Portable Scalp Cooling System (PSCS) Study: A Post-market Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Early-stage Breast Cancer","has_exemption":false,"start_date":"2024-05-16","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06207799","publication_url":"https://clinicaltrials.gov/study/NCT06207799","title":"Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma","has_exemption":false,"start_date":"2024-07-17","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06526338","publication_url":"https://clinicaltrials.gov/study/NCT06526338","title":"A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of IP-001 as Adjuvant Therapy in Participants With Hepatocellular Carcinoma After Complete Radiological Response After Surgical Resection and Local Ablation or Local Ablation Alone","has_exemption":false,"start_date":"2024-07-24","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Robert C. Martin","sponsor_slug":"robert-c-martin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06107764","publication_url":"https://clinicaltrials.gov/study/NCT06107764","title":"Cerebellar Modulation of Cognition in Psychosis","has_exemption":false,"start_date":"2024-07-31","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Mclean Hospital","sponsor_slug":"mclean-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06445946","publication_url":"https://clinicaltrials.gov/study/NCT06445946","title":"DECIDE: A Comparative Effectiveness Trial of Oral Metformin Versus Injectable Insulin for the Treatment of Gestational Diabetes","has_exemption":false,"start_date":"2024-08-01","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06061809","publication_url":"https://clinicaltrials.gov/study/NCT06061809","title":"Open-Label, Single-Arm Phase 2 Study of Nogapendekin Alfa Inbakicept, PD-L1 t-haNK, Bevacizumab and Randomized Phase 2B Study of Nogapendekin Alfa Inbakicept, Bevacizumab, and Tumor Treatment Fields With or Without PD-L1 t-haNK in Participants With Recurrent or Progressive Glioblastoma","has_exemption":false,"start_date":"2024-08-07","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"ImmunityBio, Inc.","sponsor_slug":"immunitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06518551","publication_url":"https://clinicaltrials.gov/study/NCT06518551","title":"A Phase I/II Study of Elotuzumab and Iberdomide and Dexamethasone Post Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma","has_exemption":false,"start_date":"2024-11-01","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Omar Nadeem, MD","sponsor_slug":"omar-nadeem-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06575192","publication_url":"https://clinicaltrials.gov/study/NCT06575192","title":"A Prospective, Multicenter, Open-Label, Non-Randomized, Controlled Pivotal Study to Evaluate the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix in Implant-Based Two Stage Prepectoral Breast Reconstruction Post-Mastectomy","has_exemption":false,"start_date":"2024-11-05","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06500975","publication_url":"https://clinicaltrials.gov/study/NCT06500975","title":"Long Term Outcomes After Vestibular Implantation","has_exemption":false,"start_date":"2024-12-01","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06735976","publication_url":"https://clinicaltrials.gov/study/NCT06735976","title":"Efficacy & Safety of LOBO™ Vascular Occlusion Device for Embolization of Pulmonary Arteriovenous Malformations (PAVM)","has_exemption":false,"start_date":"2024-12-17","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06711705","publication_url":"https://clinicaltrials.gov/study/NCT06711705","title":"Phase II MRD-Adapted Study of Elranatamab in Relapsed/Refractory","has_exemption":false,"start_date":"2024-12-18","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06769633","publication_url":"https://clinicaltrials.gov/study/NCT06769633","title":"A Phase 2 Open-label (Core Phase Plus Extension Phase) With 2 Cohorts Study to Assess the Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Than 6 Years Old","has_exemption":false,"start_date":"2025-01-02","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Italfarmaco","sponsor_slug":"italfarmaco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06132178","publication_url":"https://clinicaltrials.gov/study/NCT06132178","title":"Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder","has_exemption":false,"start_date":"2025-01-10","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06797635","publication_url":"https://clinicaltrials.gov/study/NCT06797635","title":"An Open-label Randomized Phase 2 Study to Evaluate Safety and Efficacy of Patritumab Deruxtecan Plus Pembrolizumab Administered Either Before or After Carboplatin/Paclitaxel Plus Pembrolizumab Compared With Pembrolizumab in Combination With Chemotherapy Followed by Surgery and Adjuvant Pembrolizumab for High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer (HERTHENA-Breast03)","has_exemption":false,"start_date":"2025-03-20","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07064018","publication_url":"https://clinicaltrials.gov/study/NCT07064018","title":"Phase Ib/IIa Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies","has_exemption":false,"start_date":"2025-04-30","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07003425","publication_url":"https://clinicaltrials.gov/study/NCT07003425","title":"A Long-term Extension Study to Evaluate the Safety and Efficacy of APG777 in Patients With Atopic Dermatitis Previously Treated With APG777","has_exemption":false,"start_date":"2025-05-14","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Apogee Therapeutics, Inc.","sponsor_slug":"apogee-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06736171","publication_url":"https://clinicaltrials.gov/study/NCT06736171","title":"Prescription of Robotic Exoskeletons for Ambulation Recovery Post Stroke","has_exemption":false,"start_date":"2025-05-15","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Kessler Foundation","sponsor_slug":"kessler-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06976801","publication_url":"https://clinicaltrials.gov/study/NCT06976801","title":"Prospective, Randomized-control Trial Comparing Standard Intramedullary Tibial Fixation With Micromotion Tibial Intramedullary Fixation","has_exemption":false,"start_date":"2025-07-01","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06765109","publication_url":"https://clinicaltrials.gov/study/NCT06765109","title":"A Phase 3 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 Compared to Alectinib in First-Line Treatment of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer (ALKAZAR)","has_exemption":false,"start_date":"2025-07-17","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Nuvalent Inc.","sponsor_slug":"nuvalent-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06508931","publication_url":"https://clinicaltrials.gov/study/NCT06508931","title":"A Single-arm, Multi-center, Open-label Phase II Study to Determine the Safety and Efficacy of MB-CART2019.1 in Pediatric Subjects With Relapsed/Refractory Mature B-cell Neoplasms Who Have Relapsed After One or More Prior Therapies, Including Subjects With Primary Refractory Disease","has_exemption":false,"start_date":"2025-08-04","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Miltenyi Biomedicine GmbH","sponsor_slug":"miltenyi-biomedicine-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06740968","publication_url":"https://clinicaltrials.gov/study/NCT06740968","title":"Improving Neural Oscillation and Synchrony Between Motor and Auditory Regions in Stuttering Using Personalized Transcranial Alternating Current Stimulation (tACS)","has_exemption":false,"start_date":"2025-08-05","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07144813","publication_url":"https://clinicaltrials.gov/study/NCT07144813","title":"Clinical Post- Approval Study of the Neuspera Sacral Neuromodulation (SNM) System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)","has_exemption":false,"start_date":"2025-09-03","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Neuspera Medical, Inc.","sponsor_slug":"neuspera-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06561074","publication_url":"https://clinicaltrials.gov/study/NCT06561074","title":"A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)","has_exemption":false,"start_date":"2025-09-25","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07449039","publication_url":"https://clinicaltrials.gov/study/NCT07449039","title":"Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial","has_exemption":false,"start_date":"2025-09-28","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07010146","publication_url":"https://clinicaltrials.gov/study/NCT07010146","title":"Role of Estrogen Formulation and Route of Delivery on Skeletal Outcomes in Functional Hypothalmic Amenorrhea","has_exemption":false,"start_date":"2025-10-01","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07173751","publication_url":"https://clinicaltrials.gov/study/NCT07173751","title":"A Phase III, Multisite, Randomized, Double-Blind Trial of BNT327 in Combination With Chemotherapy Versus Placebo With Chemotherapy in Patients With Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC Determined Ineligible for PD(L)1 Therapy Based on PD-L1 Negative Disease","has_exemption":false,"start_date":"2025-10-30","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07188532","publication_url":"https://clinicaltrials.gov/study/NCT07188532","title":"Biologically-Adapted, Dose-Escalated Accelerated Radiotherapy for Ewing Sarcoma (BEAR)","has_exemption":false,"start_date":"2025-11-24","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07454356","publication_url":"https://clinicaltrials.gov/study/NCT07454356","title":"Comparing High Intensity Stretch Device Combined With Physical Therapy Versus Physical Therapy Alone to Prevent Motion-Restoring Surgery Following Primary Total Knee Arthroplasty: Study Protocol for a Randomized Controlled Trial","has_exemption":false,"start_date":"2025-12-09","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Ermi LLC","sponsor_slug":"ermi-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07283367","publication_url":"https://clinicaltrials.gov/study/NCT07283367","title":"A Phase Ib/II Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HS-20110 Combination Therapies in Patients With Advanced Colorectal Cancer.","has_exemption":false,"start_date":"2025-12-22","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Hansoh BioMedical R&D Company","sponsor_slug":"hansoh-biomedical-rd-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220915","publication_url":"https://clinicaltrials.gov/study/NCT07220915","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Panzyga for Prevention of Major Infection in Patients With Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions Receiving Treatment With B-cell Depletion Therapy (\"PROTECT\")","has_exemption":false,"start_date":"2025-12-31","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Octapharma","sponsor_slug":"octapharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07188558","publication_url":"https://clinicaltrials.gov/study/NCT07188558","title":"A Phase 3 Randomized Controlled Trial of Rondecabtagene Autoleucel , an Autologous, Dual-targeting CD19/CD20 CAR T-Cell Product Candidate, Vs. Investigator's Choice of CD19 CAR T-Cell Therapy in Patients With Relapsed or Refractory Large B-Cell Lymphoma in the Second-line Setting","has_exemption":false,"start_date":"2026-01-12","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Lyell Immunopharma, Inc.","sponsor_slug":"lyell-immunopharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07258771","publication_url":"https://clinicaltrials.gov/study/NCT07258771","title":"Acute Severe Ulcerative Colitis- Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction While Transitioning Away From the Emergency Setting (ACUTE): A Phase IV, Single Center, Partially Blinded, Randomized Study","has_exemption":false,"start_date":"2026-01-16","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Berinstein, Jeffrey","sponsor_slug":"berinstein-jeffrey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07060638","publication_url":"https://clinicaltrials.gov/study/NCT07060638","title":"Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial","has_exemption":false,"start_date":"2026-01-27","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Samer Gawrieh","sponsor_slug":"samer-gawrieh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07380256","publication_url":"https://clinicaltrials.gov/study/NCT07380256","title":"Effects of Impaired Visual Acuity and Binocular Control Abnormalities (VABC) on Vestibulo-ocular Reflex (VOR) Adaptation in Adults With and Without Vestibular Hypofunction","has_exemption":false,"start_date":"2026-02-04","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06681220","publication_url":"https://clinicaltrials.gov/study/NCT06681220","title":"Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC","has_exemption":false,"start_date":"2026-02-23","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07497178","publication_url":"https://clinicaltrials.gov/study/NCT07497178","title":"A Prospective Cohort Study of High Intensity Focused Ultrasound Ablation for Brain Lesions in Children With Drug Resistant Epilepsy","has_exemption":false,"start_date":"2026-03-01","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"The Hospital for Sick Children","sponsor_slug":"the-hospital-for-sick-children","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07560631","publication_url":"https://clinicaltrials.gov/study/NCT07560631","title":"SeeMe: A Multimodal Behavioral-Electrophysiological Tool for Real-Time Detection of Motor Behavior in Brain Injury Patients","has_exemption":false,"start_date":"2026-03-30","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Stony Brook University","sponsor_slug":"stony-brook-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214376","publication_url":"https://clinicaltrials.gov/study/NCT07214376","title":"A Randomized Placebo-procedure Controlled Trial of the Multi-Pole Pulmonary Artery Radiofrequency Ablation Enhancor System PULmonary Artery Denervation Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease","has_exemption":false,"start_date":"2026-04-01","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Pulnovo Medical, Inc.","sponsor_slug":"pulnovo-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07112196","publication_url":"https://clinicaltrials.gov/study/NCT07112196","title":"Adaptive, Phase 2/3, Randomized, Double-Blind Trial Investigating the Efficacy and Safety of Visugromab Versus Placebo in Patients With Cancer-associated Cachexia","has_exemption":false,"start_date":"2026-04-16","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"CatalYm GmbH","sponsor_slug":"catalym-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07439094","publication_url":"https://clinicaltrials.gov/study/NCT07439094","title":"A First-in-Human, Multicenter, Open-Label, Phase 1/2a Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CKD-703 in Advanced c-Met Expressing Solid Tumors, and in MET Amplified and c-Met Overexpressing Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2026-04-16","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Chong Kun Dang Pharmaceutical","sponsor_slug":"chong-kun-dang-pharmaceutical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07162480","publication_url":"https://clinicaltrials.gov/study/NCT07162480","title":"Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)","has_exemption":false,"start_date":"2026-04-29","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07300982","publication_url":"https://clinicaltrials.gov/study/NCT07300982","title":"Studies of Insulin and Glucagon Action in the Liver","has_exemption":false,"start_date":"2026-04-30","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07556718","publication_url":"https://clinicaltrials.gov/study/NCT07556718","title":"Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease: A Multicenter Randomized Placebo-Controlled Trial","has_exemption":false,"start_date":"2026-04-30","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07112105","publication_url":"https://clinicaltrials.gov/study/NCT07112105","title":"Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder","has_exemption":false,"start_date":"2026-05-01","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07511049","publication_url":"https://clinicaltrials.gov/study/NCT07511049","title":"Safety and Tolerability of Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study","has_exemption":false,"start_date":"2026-05-11","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","sponsor_slug":"national-institute-of-neurological-disorders-and-stroke-ninds","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07308938","publication_url":"https://clinicaltrials.gov/study/NCT07308938","title":"Trial of Topical Fluorometholone as Adjunctive Therapy for Bacterial Corneal Ulcers","has_exemption":false,"start_date":"2026-05-31","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Vishal Jhanji","sponsor_slug":"vishal-jhanji","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07454980","publication_url":"https://clinicaltrials.gov/study/NCT07454980","title":"Pivotal TRIal to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With Lux Valve Plus System in Patients With Severe or Greater Tricuspid Regurgitation - Clinical SafetY and Effectiveness","has_exemption":false,"start_date":"2026-05-31","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Jenscare Innovation Inc.","sponsor_slug":"jenscare-innovation-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07394036","publication_url":"https://clinicaltrials.gov/study/NCT07394036","title":"The Effect of Ipratropium Bromide on Exercise-Induced Laryngeal Obstruction (EILO) in Pediatric Patients","has_exemption":false,"start_date":"2026-06-01","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Cook Children's Health Care System","sponsor_slug":"cook-childrens-health-care-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05494697","publication_url":"https://clinicaltrials.gov/study/NCT05494697","title":"A Phase 2 Randomized Open-Label Controlled Study to Evaluate the Efficacy and Safety of Ampligen in Combination With Standard of Care Versus SOC Alone Following First-Line Therapy in Subjects With Locally Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"AIM ImmunoTech Inc.","sponsor_slug":"aim-immunotech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06854029","publication_url":"https://clinicaltrials.gov/study/NCT06854029","title":"Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285148","publication_url":"https://clinicaltrials.gov/study/NCT07285148","title":"An Open-label, Multicenter Phase Ib/II Study to Evaluate the Safety, Efficacy and Pharmacokinetic Characteristics of ANS014004 in Combination With EGFR-TKI in Patients With EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Beijing Pearl Biotechnology Limited Liability Company","sponsor_slug":"beijing-pearl-biotechnology-limited-liability-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07564141","publication_url":"https://clinicaltrials.gov/study/NCT07564141","title":"A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer","has_exemption":false,"start_date":"2026-07-31","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06820138","publication_url":"https://clinicaltrials.gov/study/NCT06820138","title":"Low Intensity Focused Ultrasound for Posttraumatic Stress Disorder","has_exemption":false,"start_date":"2026-08-03","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07027969","publication_url":"https://clinicaltrials.gov/study/NCT07027969","title":"Efficacy of Cardiometabolic Risk Factor Control Through Metabolic Surgery on Management and Severity of Atrial Fibrillation: METSAFE Randomized Clinical Trial","has_exemption":false,"start_date":"2026-11-01","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Ali Aminian","sponsor_slug":"ali-aminian","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02864888","publication_url":"https://clinicaltrials.gov/study/NCT02864888","title":"A Controlled, Study of the Effect of Combination Antineoplaston Therapy [Atengenal (A10) and Astugenal (AS2-1)] on the QT/QTc Interval In Subjects With Newly Diagnosed Diffuse, Intrinsic, Brainstem Glioma","has_exemption":false,"start_date":"2027-06-30","completion_date":"2029-12-31","has_results":false,"results_due":false,"sponsor_name":"Burzynski Research Institute","sponsor_slug":"burzynski-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03206060","publication_url":"https://clinicaltrials.gov/study/NCT03206060","title":"Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma","has_exemption":false,"start_date":"2017-10-10","completion_date":"2030-01-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04337515","publication_url":"https://clinicaltrials.gov/study/NCT04337515","title":"A Feasibility Study of Using the CiniMacs® Device for Alpha/Best T-Cell Depletion in Stem Cell Transplant Recipients","has_exemption":false,"start_date":"2019-12-19","completion_date":"2030-01-01","has_results":false,"results_due":false,"sponsor_name":"Christopher Dvorak","sponsor_slug":"christopher-dvorak","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05088798","publication_url":"https://clinicaltrials.gov/study/NCT05088798","title":"Use of18F-DOPA PET/MRI for the Detection and Localization of Focal Forms of Hyperinsulinism","has_exemption":false,"start_date":"2020-09-10","completion_date":"2030-01-01","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02773082","publication_url":"https://clinicaltrials.gov/study/NCT02773082","title":"Reclaim™ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (OCD)","has_exemption":false,"start_date":"2024-07-06","completion_date":"2030-01-01","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06068543","publication_url":"https://clinicaltrials.gov/study/NCT06068543","title":"A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer","has_exemption":false,"start_date":"2024-10-25","completion_date":"2030-01-01","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07043972","publication_url":"https://clinicaltrials.gov/study/NCT07043972","title":"Phase II Study of Second-line Gemcitabine Plus Carboplatin After Progression on Enfortumab Vedotin With Pembrolizumab in Advanced or Metastatic Urothelial Carcinoma","has_exemption":false,"start_date":"2025-07-09","completion_date":"2030-01-01","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06440707","publication_url":"https://clinicaltrials.gov/study/NCT06440707","title":"Transcranial Electrical Stimulation in Stroke EaRly After Onset Clinical Trial 2","has_exemption":false,"start_date":"2025-07-15","completion_date":"2030-01-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07300865","publication_url":"https://clinicaltrials.gov/study/NCT07300865","title":"Does the Thickness of the Gastrostomy Affect the Incidence of Complications? A Prospective Randomized Single-Center Study in Children","has_exemption":false,"start_date":"2025-11-20","completion_date":"2030-01-01","has_results":false,"results_due":false,"sponsor_name":"Therese Hössjer","sponsor_slug":"therese-hossjer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07506239","publication_url":"https://clinicaltrials.gov/study/NCT07506239","title":"PNOC042: A Phase 2, Multi-institutional Trial, Evaluating the Efficacy of Laser Interstitial Thermal Therapy (LITT) in Children, Adolescents and Young Adults With Recurrent or Progressive Low-grade Gliomas (LGG)","has_exemption":false,"start_date":"2026-03-25","completion_date":"2030-01-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06214793","publication_url":"https://clinicaltrials.gov/study/NCT06214793","title":"A Phase II Study of Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) of the Breast (TaCe)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-01-01","has_results":false,"results_due":false,"sponsor_name":"Megan Kruse, MD","sponsor_slug":"megan-kruse-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06303193","publication_url":"https://clinicaltrials.gov/study/NCT06303193","title":"Phase I/II Trial of Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms","has_exemption":false,"start_date":"2026-05-11","completion_date":"2030-01-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220252","publication_url":"https://clinicaltrials.gov/study/NCT07220252","title":"Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)","has_exemption":false,"start_date":"2026-06-01","completion_date":"2030-01-01","has_results":false,"results_due":false,"sponsor_name":"TG Therapeutics, Inc.","sponsor_slug":"tg-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07213674","publication_url":"https://clinicaltrials.gov/study/NCT07213674","title":"A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer","has_exemption":false,"start_date":"2025-11-28","completion_date":"2030-01-07","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07335796","publication_url":"https://clinicaltrials.gov/study/NCT07335796","title":"A Phase 2 Study of Androgen Deprivation Therapy and BMS986365 in High-Risk Localized Prostate Cancer Patients Prior to Radical Prostatectomy","has_exemption":false,"start_date":"2026-01-09","completion_date":"2030-01-09","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07517263","publication_url":"https://clinicaltrials.gov/study/NCT07517263","title":"A Single Arm, Multicenter, Open-label Extension (OLE) Trial to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) in Participants Who Completed the Parent Lp(a)HORIZON Trial","has_exemption":false,"start_date":"2026-05-11","completion_date":"2030-01-09","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00109174","publication_url":"https://clinicaltrials.gov/study/NCT00109174","title":"MRS (Magnetic Resonance Spectroscopy) Measurement of Glutamate and GABA Metabolism in Brain","has_exemption":false,"start_date":"2006-09-06","completion_date":"2030-01-11","has_results":false,"results_due":false,"sponsor_name":"National Institute of Mental Health (NIMH)","sponsor_slug":"national-institute-of-mental-health-nimh","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT07459751","publication_url":"https://clinicaltrials.gov/study/NCT07459751","title":"A Randomized, Open-Label, Multi-center, Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) Monotherapy or HLX43 in Combination With HLX07 (Recombinant Anti-EGFR Humanized Monoclonal Antibody Injection) Versus Docetaxel in Previously Treated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2026-04-09","completion_date":"2030-01-15","has_results":false,"results_due":false,"sponsor_name":"Shanghai Henlius Biotech","sponsor_slug":"shanghai-henlius-biotech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05800015","publication_url":"https://clinicaltrials.gov/study/NCT05800015","title":"A Randomized, Double-Blind Phase 2/3 Study of Fianlimab (Anti-LAG-3 Antibody), Cemiplimab (Anti-PD-1 Antibody), and Chemotherapy Versus Cemiplimab and Chemotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Irrespective of PD-L1 Expression Levels","has_exemption":false,"start_date":"2023-08-08","completion_date":"2030-01-16","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01687608","publication_url":"https://clinicaltrials.gov/study/NCT01687608","title":"A Phase 1/2 Open-Label, Single Ascending Dose Trial of a Self-Complementing Optimized Adeno-associated Virus Serotype 8 Factor IX Gene Therapy (AskBio009) in Adults With Hemophilia B","has_exemption":false,"start_date":"2013-02-11","completion_date":"2030-01-17","has_results":false,"results_due":false,"sponsor_name":"Baxalta now part of Shire","sponsor_slug":"baxalta-now-part-of-shire","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT06868277","publication_url":"https://clinicaltrials.gov/study/NCT06868277","title":"A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab Monotherapy for the First-line Treatment of Patients With PD-L1-high Metastatic Non-small Cell Lung Cancer (ARTEMIDE-Lung04)","has_exemption":false,"start_date":"2025-04-10","completion_date":"2030-01-17","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06572605","publication_url":"https://clinicaltrials.gov/study/NCT06572605","title":"A Phase 1b/2 Study of Talquetamab Plus Concomitant Priming Radiotherapy in Multiple Myeloma With Extramedullary Disease","has_exemption":false,"start_date":"2025-08-29","completion_date":"2030-01-18","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07519772","publication_url":"https://clinicaltrials.gov/study/NCT07519772","title":"A Phase 1b/2 Study to Evaluate the Safety and Efficacy of MK-1045 Monotherapy or in Combination With Other Anticancer Agents in Participants With Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2026-05-07","completion_date":"2030-01-20","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07410117","publication_url":"https://clinicaltrials.gov/study/NCT07410117","title":"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of REGN7508, a Monoclonal Antibody Against FXI, for Primary Prophylaxis of Cancer-Associated Thrombosis for Participants With Solid Tumors Undergoing Cancer Treatment (ROXI-CAT-I)","has_exemption":false,"start_date":"2026-03-09","completion_date":"2030-01-23","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04638647","publication_url":"https://clinicaltrials.gov/study/NCT04638647","title":"An Open-label, Multi-center Protocol for Patients Who Have Completed a Previous Novartis Sponsored Secukinumab Study and Are Judged by the Investigator to Benefit From Continued Secukinumab Treatment","has_exemption":false,"start_date":"2020-12-22","completion_date":"2030-01-29","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04008368","publication_url":"https://clinicaltrials.gov/study/NCT04008368","title":"Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease or Beta-Thalassemia and Falling Donor Myeloid Chimerism Levels","has_exemption":false,"start_date":"2019-10-24","completion_date":"2030-01-30","has_results":false,"results_due":false,"sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","sponsor_slug":"national-heart-lung-and-blood-institute-nhlbi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05464719","publication_url":"https://clinicaltrials.gov/study/NCT05464719","title":"A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy","has_exemption":false,"start_date":"2022-09-23","completion_date":"2030-01-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06205485","publication_url":"https://clinicaltrials.gov/study/NCT06205485","title":"A Phase 3 Randomized Trial Of Neoadjuvant Chemotherapy, Excision And Observation Versus Chemoradiotherapy For Early Rectal Cancer","has_exemption":false,"start_date":"2024-06-26","completion_date":"2030-01-30","has_results":false,"results_due":false,"sponsor_name":"Canadian Cancer Trials Group","sponsor_slug":"canadian-cancer-trials-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07399977","publication_url":"https://clinicaltrials.gov/study/NCT07399977","title":"A Nonrandomized Trial Using DNA Liquid Biopsies to Guide Anticoagulation For Patients With Cancer-Associated Thromboembolism","has_exemption":false,"start_date":"2026-01-30","completion_date":"2030-01-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00785525","publication_url":"https://clinicaltrials.gov/study/NCT00785525","title":"Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors","has_exemption":false,"start_date":"1997-02-28","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Center for International Blood and Marrow Transplant Research","sponsor_slug":"center-for-international-blood-and-marrow-transplant-research","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02605785","publication_url":"https://clinicaltrials.gov/study/NCT02605785","title":"A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy","has_exemption":false,"start_date":"2015-11-30","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03599752","publication_url":"https://clinicaltrials.gov/study/NCT03599752","title":"The Role of Multimodality Management in Risk-Stratified Patients With Lung-Limited Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2018-07-02","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03801083","publication_url":"https://clinicaltrials.gov/study/NCT03801083","title":"A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Locally Advanced, Recurrent, or Metastatic Biliary Tract Cancers","has_exemption":false,"start_date":"2019-02-19","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Udai Kammula","sponsor_slug":"udai-kammula","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04375722","publication_url":"https://clinicaltrials.gov/study/NCT04375722","title":"Exogenous Tuning of Neural Oscillations as a Mode of Treatment in Post-stroke Aphasia","has_exemption":false,"start_date":"2020-01-04","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05030441","publication_url":"https://clinicaltrials.gov/study/NCT05030441","title":"A Pilot Study of Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1","has_exemption":false,"start_date":"2022-04-01","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05554302","publication_url":"https://clinicaltrials.gov/study/NCT05554302","title":"Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis","has_exemption":false,"start_date":"2023-01-10","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Baptist Health South Florida","sponsor_slug":"baptist-health-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05643742","publication_url":"https://clinicaltrials.gov/study/NCT05643742","title":"A Phase 1/2, Open-Label, Multicenter, Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD19 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX112) in Subjects With Relapsed or Refractory B Cell Malignancies","has_exemption":false,"start_date":"2023-03-10","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"CRISPR Therapeutics AG","sponsor_slug":"crispr-therapeutics-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06193551","publication_url":"https://clinicaltrials.gov/study/NCT06193551","title":"Ovitex in Paraesophageal and Large Hiatal Hernia Repair. (OviPHeR)","has_exemption":false,"start_date":"2024-02-19","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Foregut Research Foundation","sponsor_slug":"foregut-research-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06412666","publication_url":"https://clinicaltrials.gov/study/NCT06412666","title":"A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled and Open-Label Extension Trial to Evaluate the Efficacy and Safety of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy","has_exemption":false,"start_date":"2024-05-29","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Cytokinetics","sponsor_slug":"cytokinetics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06559176","publication_url":"https://clinicaltrials.gov/study/NCT06559176","title":"A Phase 1/2 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Modified Ex Vivo Using Prime Editing (PM359) in Participants With Autosomal Recessive Chronic Granulomatous Disease Due to Mutations in the NCF1 Gene","has_exemption":false,"start_date":"2024-10-17","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Prime Medicine, Inc.","sponsor_slug":"prime-medicine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06857773","publication_url":"https://clinicaltrials.gov/study/NCT06857773","title":"Hepatic Arterial Infusion PUMP Chemotherapy Combined With Systemic Therapy Versus Systemic Therapy Alone as Induction Therapy for Initially Unresectable Colorectal Liver Metastases: a Randomised Controlled Trial","has_exemption":false,"start_date":"2024-11-21","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"The Netherlands Cancer Institute","sponsor_slug":"the-netherlands-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06581406","publication_url":"https://clinicaltrials.gov/study/NCT06581406","title":"A Randomized, Phase 2/3, Open-Label Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab Versus Ipilimumab in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma","has_exemption":false,"start_date":"2024-12-17","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Replimune Inc.","sponsor_slug":"replimune-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06607406","publication_url":"https://clinicaltrials.gov/study/NCT06607406","title":"A Randomized Trial of Accelerated Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC (Head and Neck Squamous Cell Carcinoma) Initiating Radiotherapy Greater Than 6 Weeks After Surgery (PORTRush)","has_exemption":false,"start_date":"2025-01-21","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06781931","publication_url":"https://clinicaltrials.gov/study/NCT06781931","title":"DG1 Spectacle Lens for Myopia Progression Control in Children: A Three-year Multicenter, Prospective, Randomized, Double-masked, Controlled Clinical Trial to Evaluate the Efficacy and Safety Followed by a One-year Rebound Evaluation","has_exemption":false,"start_date":"2025-01-21","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"HOYA Lens Thailand LTD.","sponsor_slug":"hoya-lens-thailand-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06842355","publication_url":"https://clinicaltrials.gov/study/NCT06842355","title":"A Multicenter, Phase 2, Dose-Escalation/Dose-Expansion Study of TYRA-300 in Children With Achondroplasia With Open Growth Plates: BEACH301","has_exemption":false,"start_date":"2025-03-04","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Tyra Biosciences, Inc","sponsor_slug":"tyra-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06717438","publication_url":"https://clinicaltrials.gov/study/NCT06717438","title":"A Phase 2 Randomized, Double-blind, Placebo-controlled, Study of Zatolmilast (BPN14770) in Subjects With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome)","has_exemption":false,"start_date":"2025-05-13","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Shionogi","sponsor_slug":"shionogi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06745882","publication_url":"https://clinicaltrials.gov/study/NCT06745882","title":"Prospective Trial to Assess Real-world Outcomes and Predictive Biomarkers of Response to Pembrolizumab With or Without Chemotherapy in Black Patients With NSCLC","has_exemption":false,"start_date":"2025-06-13","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07076225","publication_url":"https://clinicaltrials.gov/study/NCT07076225","title":"A Ultrashort Regimen for Drug-susceptible Pulmonary Tuberculosis in Elderly Patients: A Multicenter Randomized Controlled Trial","has_exemption":false,"start_date":"2025-07-25","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Shenzhen Third People's Hospital","sponsor_slug":"shenzhen-third-peoples-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07213661","publication_url":"https://clinicaltrials.gov/study/NCT07213661","title":"Long-term Comparative Effectiveness of 2 Treatments to Arrest Dental Caries in Older Adults","has_exemption":false,"start_date":"2025-10-08","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Case Western Reserve University","sponsor_slug":"case-western-reserve-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07157254","publication_url":"https://clinicaltrials.gov/study/NCT07157254","title":"A Phase 2, Open-label, Basket Study Investigating the Safety and Efficacy of GTX-102 in Adult and Pediatric Subjects With Deletion- or Nondeletion-type Angelman Syndrome","has_exemption":false,"start_date":"2025-10-13","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Ultragenyx Pharmaceutical Inc","sponsor_slug":"ultragenyx-pharmaceutical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06200259","publication_url":"https://clinicaltrials.gov/study/NCT06200259","title":"Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement","has_exemption":false,"start_date":"2025-12-15","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Covenant Health Cancer Center","sponsor_slug":"covenant-health-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223307","publication_url":"https://clinicaltrials.gov/study/NCT07223307","title":"Phase II Trial of REal Time MRI GUided Adaptive Stereotactic Ablative Radiotherapy for Liver Cancers Using a Single Session, Simulation Free Workflow","has_exemption":false,"start_date":"2026-01-23","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07129473","publication_url":"https://clinicaltrials.gov/study/NCT07129473","title":"Hyperemesis Gravidarum Risk Reduction With Metformin","has_exemption":false,"start_date":"2026-01-31","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07303946","publication_url":"https://clinicaltrials.gov/study/NCT07303946","title":"Double-Blind, Crossover, Feasibility Study of Deep Brain Stimulation of the Anterior Cingulate Bundle (ACB) and the Ventral Anterior Limb of the Internal Capsule (vALIC) in Patients With Intractable Obsessive Compulsive Disorder (OCD)","has_exemption":false,"start_date":"2026-01-31","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Rhode Island Hospital","sponsor_slug":"rhode-island-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07369115","publication_url":"https://clinicaltrials.gov/study/NCT07369115","title":"Intra-Cellular Therapies, Inc. / \"A Randomized, Double-blind, Placebo-controlled, Single Site Study to Evaluate the Efficacy of Lumateperone for the Treatment of Major Depressive Disorder (MDD) and Early Life Trauma in Adult Patients Aged 21 to 70 Years","has_exemption":false,"start_date":"2026-02-28","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07280468","publication_url":"https://clinicaltrials.gov/study/NCT07280468","title":"Endotype DIrected Treatment for OSA in Down Syndrome","has_exemption":false,"start_date":"2026-03-14","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07497399","publication_url":"https://clinicaltrials.gov/study/NCT07497399","title":"Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis (TAG-MS): A Phase 2, Randomized, Double-Blind, Parallel-Arm Study","has_exemption":false,"start_date":"2026-04-28","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288151","publication_url":"https://clinicaltrials.gov/study/NCT07288151","title":"MDMA-Assisted Massed Exposure Therapy for PTSD","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07546812","publication_url":"https://clinicaltrials.gov/study/NCT07546812","title":"A Phase 2, Open-Label, Multicenter, Randomized Study to Evaluate Denikitug as Monotherapy or in Combination With Nivolumab or Chemotherapy in Participants With HER2-Negative, Unresectable, Recurrent, and/or Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07328503","publication_url":"https://clinicaltrials.gov/study/NCT07328503","title":"A Phase II Study to Examine the Impact of CD22 CAR T-cells to Extend the Duration of Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2026-05-11","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07010302","publication_url":"https://clinicaltrials.gov/study/NCT07010302","title":"A Comparative Clinical Effectiveness Trial of Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab and Eculizumab To Prevent Relapses in Neuromyelitis Optica Spectrum Disorder","has_exemption":false,"start_date":"2026-05-31","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07332442","publication_url":"https://clinicaltrials.gov/study/NCT07332442","title":"Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep Apnea","has_exemption":false,"start_date":"2026-05-31","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07264920","publication_url":"https://clinicaltrials.gov/study/NCT07264920","title":"Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain","has_exemption":false,"start_date":"2026-06-30","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07419425","publication_url":"https://clinicaltrials.gov/study/NCT07419425","title":"Comparing Three Multicomponent Interventions to Help Adults Quit Smoking","has_exemption":false,"start_date":"2026-06-30","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07069699","publication_url":"https://clinicaltrials.gov/study/NCT07069699","title":"Phase 1b/2 Trial of Pidnarulex in MYC Aberrant Lymphoma","has_exemption":false,"start_date":"2026-10-13","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07470164","publication_url":"https://clinicaltrials.gov/study/NCT07470164","title":"A Randomized Trial of Botulinum Toxin A vs Strabismus Surgery for Esotropia >10 to ≤30PD","has_exemption":false,"start_date":"2027-01-31","completion_date":"2030-01-31","has_results":false,"results_due":false,"sponsor_name":"Jaeb Center for Health Research","sponsor_slug":"jaeb-center-for-health-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01754363","publication_url":"https://clinicaltrials.gov/study/NCT01754363","title":"Short, Medium and Long Term Survivorship of Attune Primary Knee Prosthesis","has_exemption":false,"start_date":"2013-02-01","completion_date":"2030-02-01","has_results":false,"results_due":false,"sponsor_name":"DePuy International","sponsor_slug":"depuy-international","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT06853665","publication_url":"https://clinicaltrials.gov/study/NCT06853665","title":"A Pharmaco-Imaging Trial of Mixed Amphetamine Salts for the Treatment of ADHD in Intellectually-intact Youth With Autism Spectrum Disorder","has_exemption":false,"start_date":"2026-02-01","completion_date":"2030-02-01","has_results":false,"results_due":false,"sponsor_name":"Gagan Joshi","sponsor_slug":"gagan-joshi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07439510","publication_url":"https://clinicaltrials.gov/study/NCT07439510","title":"A Phase 2b/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SPG601 in Male Participants With Fragile X Syndrome","has_exemption":false,"start_date":"2026-03-01","completion_date":"2030-02-01","has_results":false,"results_due":false,"sponsor_name":"Spinogenix","sponsor_slug":"spinogenix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07313787","publication_url":"https://clinicaltrials.gov/study/NCT07313787","title":"Prospective Cross-Over Study of the Effects of Meal Macronutrients on Postprandial Lipids","has_exemption":false,"start_date":"2026-05-11","completion_date":"2030-02-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284641","publication_url":"https://clinicaltrials.gov/study/NCT07284641","title":"Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)","has_exemption":false,"start_date":"2026-05-15","completion_date":"2030-02-01","has_results":false,"results_due":false,"sponsor_name":"Paul Szabolcs","sponsor_slug":"paul-szabolcs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07061951","publication_url":"https://clinicaltrials.gov/study/NCT07061951","title":"A Phase 2 Pilot Study of Mirdametinib in Relapsed Refractory Chronic Lymphocytic Leukemia","has_exemption":false,"start_date":"2026-09-08","completion_date":"2030-02-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06732388","publication_url":"https://clinicaltrials.gov/study/NCT06732388","title":"Repurposing Itraconazole for Secondary Prevention of Metaplasia and Primary Prevention of Cancer in Patients With High-Risk Barrett's Esophagus in Combination With Ablation","has_exemption":false,"start_date":"2026-10-06","completion_date":"2030-02-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221357","publication_url":"https://clinicaltrials.gov/study/NCT07221357","title":"ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2025-12-31","completion_date":"2030-02-02","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06413680","publication_url":"https://clinicaltrials.gov/study/NCT06413680","title":"A Phase 1/2a, Open-Label, Dose Escalation and Dose Expansion First-In-Human Study of the Safety, Tolerability, Activity, and Pharmacokinetics of REGN10597 (Anti-PD-1-IL-2RA-IL-2 Fusion Protein) Alone or in Combination With Cemiplimab in Patients With Advanced Solid Organ Malignancies","has_exemption":false,"start_date":"2024-09-23","completion_date":"2030-02-03","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07401823","publication_url":"https://clinicaltrials.gov/study/NCT07401823","title":"An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of Pociredir in Participants With Sickle Cell Disease (SCD) Who Have Participated in a Pociredir Study","has_exemption":false,"start_date":"2026-03-30","completion_date":"2030-02-04","has_results":false,"results_due":false,"sponsor_name":"Fulcrum Therapeutics","sponsor_slug":"fulcrum-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03309332","publication_url":"https://clinicaltrials.gov/study/NCT03309332","title":"OSB Lead-AMPLATZER PFO Occluder New Enrollment PAS","has_exemption":false,"start_date":"2018-01-31","completion_date":"2030-02-05","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07486921","publication_url":"https://clinicaltrials.gov/study/NCT07486921","title":"Etrasimod as Primary and Secondary Prevention of Pouchitis (ESPIRIT)","has_exemption":false,"start_date":"2026-03-31","completion_date":"2030-02-06","has_results":false,"results_due":false,"sponsor_name":"Maia Kayal","sponsor_slug":"maia-kayal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04528082","publication_url":"https://clinicaltrials.gov/study/NCT04528082","title":"A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study, Followed by an Active Treatment Phase to Evaluate the Efficacy and Safety of Apremilast in Children From 2 to Less Than 18 Years of Age With Active Oral Ulcers Associated With Behçet's Disease (BEAN)","has_exemption":false,"start_date":"2021-09-09","completion_date":"2030-02-07","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04980872","publication_url":"https://clinicaltrials.gov/study/NCT04980872","title":"A Multicenter, Open-label, Phase 2, Extension Trial to Study the Long-term Safety in Participants With PROS or Proteus Syndrome Who Are Currently Being Treated With Miransertib in Other Studies","has_exemption":false,"start_date":"2021-11-02","completion_date":"2030-02-07","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06799390","publication_url":"https://clinicaltrials.gov/study/NCT06799390","title":"Vagus Nerve Stimulation Following Intracerebral Hemorrhage (IHC) to Mitigate ICH-induced Inflammation and Cerebral Edema","has_exemption":false,"start_date":"2025-04-06","completion_date":"2030-02-09","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07142343","publication_url":"https://clinicaltrials.gov/study/NCT07142343","title":"An Open-Label, Single-Arm Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Pozelimab in Pediatric Patients 1 to 5 Years of Age With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)","has_exemption":false,"start_date":"2026-03-19","completion_date":"2030-02-12","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07204249","publication_url":"https://clinicaltrials.gov/study/NCT07204249","title":"Glutide for Ending Methamphetamine","has_exemption":false,"start_date":"2026-01-15","completion_date":"2030-02-15","has_results":false,"results_due":false,"sponsor_name":"San Francisco Department of Public Health","sponsor_slug":"san-francisco-department-of-public-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07539454","publication_url":"https://clinicaltrials.gov/study/NCT07539454","title":"Phase II Study of Nirogacestat in Patients With Kaposi Sarcoma","has_exemption":false,"start_date":"2026-09-17","completion_date":"2030-02-17","has_results":false,"results_due":false,"sponsor_name":"AIDS Malignancy Consortium","sponsor_slug":"aids-malignancy-consortium","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03813407","publication_url":"https://clinicaltrials.gov/study/NCT03813407","title":"An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia","has_exemption":false,"start_date":"2019-04-02","completion_date":"2030-02-21","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07000149","publication_url":"https://clinicaltrials.gov/study/NCT07000149","title":"A Phase Ib/III Randomized, Multicenter, Global Study of Volrustomig Plus Casdatifan or Volrustomig Monotherapy Versus Nivolumab Plus Ipilimumab as First-line Treatment for Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)","has_exemption":false,"start_date":"2025-07-28","completion_date":"2030-02-21","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07497087","publication_url":"https://clinicaltrials.gov/study/NCT07497087","title":"A Double-blind, Randomised, Placebo-controlled Trial Evaluating the Efficacy and Safety of Oral Nerandomilast Treatment in Patients With Systemic Sclerosis (SSc)","has_exemption":false,"start_date":"2026-06-09","completion_date":"2030-02-26","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04104776","publication_url":"https://clinicaltrials.gov/study/NCT04104776","title":"A Phase 1/2 Study of DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas","has_exemption":false,"start_date":"2019-09-18","completion_date":"2030-02-27","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00338377","publication_url":"https://clinicaltrials.gov/study/NCT00338377","title":"Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma","has_exemption":false,"start_date":"2006-02-01","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01966367","publication_url":"https://clinicaltrials.gov/study/NCT01966367","title":"CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplantation for Non-Malignant Disease","has_exemption":false,"start_date":"2013-03-31","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Diane George","sponsor_slug":"diane-george","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02912312","publication_url":"https://clinicaltrials.gov/study/NCT02912312","title":"Shortening Adjuvant Photon Irradiation to Reduce Edema (SAPHIRE): A Randomized Trial of Hypofractionated Versus Conventionally Fractionated Regional Nodal Irradiation for Invasive Breast Cancer","has_exemption":false,"start_date":"2017-02-23","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03424850","publication_url":"https://clinicaltrials.gov/study/NCT03424850","title":"A Phase I/II Dose-escalation Study Evaluating the Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy","has_exemption":false,"start_date":"2018-02-27","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03726554","publication_url":"https://clinicaltrials.gov/study/NCT03726554","title":"Comprehensive Reverse Shoulder: Porous Augmented Glenoid Baseplate and Mini Humeral Tray Post-Market Clinical Follow-up Study","has_exemption":false,"start_date":"2018-08-28","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04408352","publication_url":"https://clinicaltrials.gov/study/NCT04408352","title":"Selective Bladder Denervation Using RF Energy for the Treatment of UUI","has_exemption":false,"start_date":"2020-04-27","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Hologic, Inc.","sponsor_slug":"hologic-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04989803","publication_url":"https://clinicaltrials.gov/study/NCT04989803","title":"A Phase 1/2 Open-label, Multicenter Study Evaluating the Safety and Efficacy of KITE-363 or KITE-753, Autologous Anti-CD19/CD20 CAR T-cell Therapies, in Subjects With Relapsed and/or Refractory B-cell Lymphoma","has_exemption":false,"start_date":"2021-10-27","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Kite, A Gilead Company","sponsor_slug":"kite-a-gilead-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06128564","publication_url":"https://clinicaltrials.gov/study/NCT06128564","title":"A Two-Part, Open-Label Systemic Gene Delivery Study to Evaluate the Safety and Expression of RO7494222 (SRP-9001) in Subjects Under the Age of Four With Duchenne Muscular Dystrophy","has_exemption":false,"start_date":"2023-11-29","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06528314","publication_url":"https://clinicaltrials.gov/study/NCT06528314","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH","has_exemption":false,"start_date":"2024-09-04","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Akero Therapeutics, Inc","sponsor_slug":"akero-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06433635","publication_url":"https://clinicaltrials.gov/study/NCT06433635","title":"Sequential Multiple Assignment Randomized Trial for Bipolar Depression","has_exemption":false,"start_date":"2024-10-01","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06895785","publication_url":"https://clinicaltrials.gov/study/NCT06895785","title":"Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial","has_exemption":false,"start_date":"2025-02-21","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06839976","publication_url":"https://clinicaltrials.gov/study/NCT06839976","title":"CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Adolescents and Young Adults With Systemic Lupus Erythematosus (SLE)","has_exemption":false,"start_date":"2025-05-06","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06919666","publication_url":"https://clinicaltrials.gov/study/NCT06919666","title":"Phase Ib/II Study of NT219 in Combination With Pembrolizumab or Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)","has_exemption":false,"start_date":"2025-06-12","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06903923","publication_url":"https://clinicaltrials.gov/study/NCT06903923","title":"Bone Metabolism in Adolescents Undergoing GLP-1 Receptor Agonist Therapy","has_exemption":false,"start_date":"2025-07-31","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07003997","publication_url":"https://clinicaltrials.gov/study/NCT07003997","title":"Janus Kinase (JAK) Signaling in Depression","has_exemption":false,"start_date":"2025-09-03","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07278505","publication_url":"https://clinicaltrials.gov/study/NCT07278505","title":"Pathophysiological Mechanisms of Cannabidiol in Stress Regulation","has_exemption":false,"start_date":"2025-10-28","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06990269","publication_url":"https://clinicaltrials.gov/study/NCT06990269","title":"A Phase 2, Randomized, Masked, Placebo-Controlled Study of Subcutaneously Administered ADX-038 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)","has_exemption":false,"start_date":"2025-11-10","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"ADARx Pharmaceuticals, Inc.","sponsor_slug":"adarx-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06890338","publication_url":"https://clinicaltrials.gov/study/NCT06890338","title":"A Single-Arm, Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab Soravtansine in Subjects With FRα-Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer","has_exemption":false,"start_date":"2025-11-21","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06686771","publication_url":"https://clinicaltrials.gov/study/NCT06686771","title":"Consolidative Use of Radiotherapy to Block (CURB2) Oligoprogression In Patients With Metastatic Non-Small-Cell Lung Cancer","has_exemption":false,"start_date":"2025-12-16","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Canadian Cancer Trials Group","sponsor_slug":"canadian-cancer-trials-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07278557","publication_url":"https://clinicaltrials.gov/study/NCT07278557","title":"Assessment of Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia Following Radiotherapy for Oropharynx Cancer","has_exemption":false,"start_date":"2026-01-28","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625190","publication_url":"https://clinicaltrials.gov/study/NCT06625190","title":"Allogeneic Stem Cell Transplantation Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion With Zoledronic Acid in Combination to Treat Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory Solid Tumors","has_exemption":false,"start_date":"2026-02-11","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07318480","publication_url":"https://clinicaltrials.gov/study/NCT07318480","title":"Cognitively-enhanced tDCS of the Dorsolateral Prefrontal Cortex to Reduce Craving in Cocaine Addiction","has_exemption":false,"start_date":"2026-02-25","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290621","publication_url":"https://clinicaltrials.gov/study/NCT07290621","title":"Phase II Trial of Neoadjuvant Toripalimab in Combination With Chemotherapy Followed by Transoral Robotic Surgery or Risk/Response Stratified Chemoradiotherapy for Locoregional HPV16+ Oropharyngeal Cancer: TARGET HPV Cohort 2","has_exemption":false,"start_date":"2026-02-28","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07300956","publication_url":"https://clinicaltrials.gov/study/NCT07300956","title":"Comparing Medication Treatments for Neurodevelopmental Differences in Young Children on Rates of Beneficial Response","has_exemption":false,"start_date":"2026-02-28","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06871488","publication_url":"https://clinicaltrials.gov/study/NCT06871488","title":"Identification of Neural Markers of Aggression and Irritability and Their Capacity to Predict Treatment Response to CNS Stimulant Medication in Youth With ADHD","has_exemption":false,"start_date":"2026-03-05","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07459647","publication_url":"https://clinicaltrials.gov/study/NCT07459647","title":"An Open-Label Study to Assess the Long-Term Safety, Tolerability, and Effectiveness of ML-007C-MA in Adult Participants With Schizophrenia","has_exemption":false,"start_date":"2026-03-31","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"MapLight Therapeutics","sponsor_slug":"maplight-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07318714","publication_url":"https://clinicaltrials.gov/study/NCT07318714","title":"A Phase 1/2 Multicenter, Open-label, Dose Escalation Study Followed by a Randomized, Double-blind Sham-controlled Dose Expansion Study to Evaluate the Safety, Tolerability and Efficacy of ASP2246 in Adult Participants Who Have Motor Dysfunction Associated With Late Subacute to Chronic Ischemic Stroke Due to Supratentorial Perforator Area Infarction","has_exemption":false,"start_date":"2026-04-03","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Inc","sponsor_slug":"astellas-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06824649","publication_url":"https://clinicaltrials.gov/study/NCT06824649","title":"SMART Use of Biologics in Chronic Rhinosinusitis With Nasal Polyposis","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226869","publication_url":"https://clinicaltrials.gov/study/NCT07226869","title":"Computer Guided Microwave Liver Ablation","has_exemption":false,"start_date":"2026-05-01","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"NE Scientific INC","sponsor_slug":"ne-scientific-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07166393","publication_url":"https://clinicaltrials.gov/study/NCT07166393","title":"Multi-institutional Phase 2/3 Trial of Valproic Acid in Patients With Moderate to Severe Traumatic Brain Injury","has_exemption":false,"start_date":"2026-05-31","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07460375","publication_url":"https://clinicaltrials.gov/study/NCT07460375","title":"A First-in-Human Phase 1/2, Dose Escalation and Dose Expansion Study to Evaluate Safety, Tolerability, and Preliminary Efficacy of Claudin18.2 (CLDN18.2)-Directed Antibody-Drug Conjugate (ADC) LCB02A in Patients With CLDN18.2-positive Advanced Solid Tumors","has_exemption":false,"start_date":"2026-08-31","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"LigaChem Biosciences, Inc.","sponsor_slug":"ligachem-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07129759","publication_url":"https://clinicaltrials.gov/study/NCT07129759","title":"A Long-term Extension Study to Evaluate the Safety and Tolerability of Daily Oral LUM-201 in Children With Growth Hormone Deficiency (GHD)","has_exemption":false,"start_date":"2026-09-30","completion_date":"2030-02-28","has_results":false,"results_due":false,"sponsor_name":"Lumos Pharma","sponsor_slug":"lumos-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06315322","publication_url":"https://clinicaltrials.gov/study/NCT06315322","title":"A MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE LONG-TERM SAFETY AND TOLERABILITY OF BRIVARACETAM IN STUDY PARTICIPANTS WITH CHILDHOOD ABSENCE EPILEPSY OR JUVENILE ABSENCE EPILEPSY","has_exemption":false,"start_date":"2024-07-10","completion_date":"2030-03-01","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06532123","publication_url":"https://clinicaltrials.gov/study/NCT06532123","title":"Mechanisms of Improving Fecal Continence Muscles Motor Function in Health and Disease","has_exemption":false,"start_date":"2025-07-15","completion_date":"2030-03-01","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04774536","publication_url":"https://clinicaltrials.gov/study/NCT04774536","title":"Transplantation of CRISPRCas9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease","has_exemption":false,"start_date":"2025-08-22","completion_date":"2030-03-01","has_results":false,"results_due":false,"sponsor_name":"Mark Walters, MD","sponsor_slug":"mark-walters-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05713799","publication_url":"https://clinicaltrials.gov/study/NCT05713799","title":"Phase II Trial of the Combination of Alpha-lipoic Acid and Mirabegron in Women and in Men With Obesity","has_exemption":false,"start_date":"2026-05-11","completion_date":"2030-03-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06965114","publication_url":"https://clinicaltrials.gov/study/NCT06965114","title":"A Phase 1 Study of Combination Tovorafenib (DAY101) and Rituximab Treatment in Relapsed or Refractory Classical Hairy Cell Leukemia and Phase 2 Randomized Study Comparing Tovorafenib (DAY101) and Rituximab With Cladribine and Rituximab for Front-Line Treatment of Classical Hairy Cell Leukemia","has_exemption":false,"start_date":"2026-06-27","completion_date":"2030-03-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04200729","publication_url":"https://clinicaltrials.gov/study/NCT04200729","title":"Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis","has_exemption":false,"start_date":"2027-03-01","completion_date":"2030-03-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05952557","publication_url":"https://clinicaltrials.gov/study/NCT05952557","title":"CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease","has_exemption":false,"start_date":"2023-10-05","completion_date":"2030-03-04","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06899126","publication_url":"https://clinicaltrials.gov/study/NCT06899126","title":"A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan in Combination With Pembrolizumab Versus Platinum-based Chemotherapy in Combination With Pembrolizumab, as First-line Therapy in Participants With Locally Advanced Unresectable or Metastatic HER2 Overexpressing and PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer (DESTINY-Lung06)","has_exemption":false,"start_date":"2025-10-24","completion_date":"2030-03-05","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03148418","publication_url":"https://clinicaltrials.gov/study/NCT03148418","title":"An Open-Label, Multicenter Extension and Long-Term Observational Study in Patients Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study","has_exemption":false,"start_date":"2017-09-20","completion_date":"2030-03-06","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06869551","publication_url":"https://clinicaltrials.gov/study/NCT06869551","title":"A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Children and Adolescents From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis","has_exemption":false,"start_date":"2025-03-13","completion_date":"2030-03-06","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05837897","publication_url":"https://clinicaltrials.gov/study/NCT05837897","title":"A Phase 3, Multicenter, Randomized, Parallel-Group, Double-blind, Placebo-Controlled Induction Study Followed by an Open-label Extension Period to Evaluate the Efficacy and Safety of Intravenous Vedolizumab (300 mg) Infusion Treatment in Subjects in China With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2023-06-16","completion_date":"2030-03-08","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07424404","publication_url":"https://clinicaltrials.gov/study/NCT07424404","title":"A Phase 3 Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of KarXT in Adolescents (13 to 17 Years of Age) With Schizophrenia and KarXT+KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder","has_exemption":false,"start_date":"2026-03-31","completion_date":"2030-03-08","has_results":false,"results_due":false,"sponsor_name":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","sponsor_slug":"karuna-therapeutics-inc-a-bristol-myers-squibb-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05785767","publication_url":"https://clinicaltrials.gov/study/NCT05785767","title":"A Randomized, Double-Blind Phase 2/3 Study of Fianlimab (Anti-LAG-3 Antibody) in Combination With Cemiplimab (Anti-PD-1 Antibody) Versus Cemiplimab Monotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Tumors Expressing PD-L1 ≥50%","has_exemption":false,"start_date":"2023-06-30","completion_date":"2030-03-11","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05646381","publication_url":"https://clinicaltrials.gov/study/NCT05646381","title":"A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis [Lp(a)FRONTIERS CAVS]","has_exemption":false,"start_date":"2024-03-07","completion_date":"2030-03-12","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07483307","publication_url":"https://clinicaltrials.gov/study/NCT07483307","title":"Impact of Neoadjuvant Endocrine Therapy on Surgical Outcomes in Patients With Stage 2 to 3 Invasive Lobular Carcinoma: A Prospective Study","has_exemption":false,"start_date":"2026-03-13","completion_date":"2030-03-13","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06987539","publication_url":"https://clinicaltrials.gov/study/NCT06987539","title":"A Phase 2 Open-label Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children From 2 Years to Less Than 18 Years of Age With Generalized Myasthenia Gravis (gMG)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-03-13","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06565507","publication_url":"https://clinicaltrials.gov/study/NCT06565507","title":"A Double-blind Multicenter, Randomized Controlled Trial of Single and Multiple Dose Regimens of Oxfendazole for Mild (One or Two Lesions) Parenchymal Brain Cysticercosis, With an Open Comparison Group","has_exemption":false,"start_date":"2026-12-01","completion_date":"2030-03-15","has_results":false,"results_due":false,"sponsor_name":"Universidad Peruana Cayetano Heredia","sponsor_slug":"universidad-peruana-cayetano-heredia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05691478","publication_url":"https://clinicaltrials.gov/study/NCT05691478","title":"A Feasibility and Randomized Phase 2/3 Study of the VEGFR2/MET Inhibitor Cabozantinib in Combination With Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma","has_exemption":false,"start_date":"2023-03-03","completion_date":"2030-03-20","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06042569","publication_url":"https://clinicaltrials.gov/study/NCT06042569","title":"Dose Reduction of Docetaxel-Based Chemotherapy in Vulnerable Older Women With Early-Stage Breast Cancer (DOROTHY)","has_exemption":false,"start_date":"2024-09-16","completion_date":"2030-03-20","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07253285","publication_url":"https://clinicaltrials.gov/study/NCT07253285","title":"Efficacy, Safety and Pharmacokinetics of Cagrilintide s.c. 2.4 mg as Monotherapy and in Combination With Semaglutide s.c. 2.4 mg (CagriSema) Once Weekly for Weight Management in Chidren and Adolescents With Overweight or Obesity","has_exemption":false,"start_date":"2026-01-08","completion_date":"2030-03-20","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07178301","publication_url":"https://clinicaltrials.gov/study/NCT07178301","title":"Elective Neck Dosing in Low Risk Oropharyngeal Human Papillomavirus-Related Cancer Treatment (ENLIGHT): A Single Arm Prospective Phase II Assessing 30 Gy Elective Neck Dose","has_exemption":false,"start_date":"2026-03-20","completion_date":"2030-03-20","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05753306","publication_url":"https://clinicaltrials.gov/study/NCT05753306","title":"A Phase II Study of Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients With Gastric Cancer and Limited Peritoneal Metastasis: ROBO-CHIP Trial","has_exemption":false,"start_date":"2023-04-20","completion_date":"2030-03-25","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06347055","publication_url":"https://clinicaltrials.gov/study/NCT06347055","title":"Neuronavigated Non-invasive Brain Stimulation for Nicotine Dependence.","has_exemption":false,"start_date":"2024-10-01","completion_date":"2030-03-25","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05125016","publication_url":"https://clinicaltrials.gov/study/NCT05125016","title":"Phase 1/2 Study of REGN4336 (a PSMAxCD3 Bispecific Antibody) Administered Alone or in Combination With REGN5678 (a PSMAxCD28 Bispecific Antibody) in Patients With Metastatic Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2021-11-30","completion_date":"2030-03-28","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05352919","publication_url":"https://clinicaltrials.gov/study/NCT05352919","title":"A Multicenter, Randomized, Dose-Blind, Phase 3 Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2022-06-10","completion_date":"2030-03-29","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222800","publication_url":"https://clinicaltrials.gov/study/NCT07222800","title":"AN INTERVENTIONAL, PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN TREATMENT-NAÏVE PARTICIPANTS WITH METASTATIC COLORECTAL CANCER","has_exemption":false,"start_date":"2025-12-11","completion_date":"2030-03-29","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07446855","publication_url":"https://clinicaltrials.gov/study/NCT07446855","title":"A Modular Open-label, Phase I/IIa Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Ascending Doses of AZD4956 as Monotherapy, and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Repair Defective Solid Tumours","has_exemption":false,"start_date":"2026-03-17","completion_date":"2030-03-29","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07404826","publication_url":"https://clinicaltrials.gov/study/NCT07404826","title":"A Randomized, Sham Controlled Clinical Trial to Assess the Effectiveness of a Positive End Expiratory Device for Accelerating and Maintaining Pulmonary Rehabilitation Gains","has_exemption":false,"start_date":"2026-04-01","completion_date":"2030-03-29","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06439693","publication_url":"https://clinicaltrials.gov/study/NCT06439693","title":"A Single-Arm, Phase II Study of Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer: The SAPPHO Study","has_exemption":false,"start_date":"2024-08-08","completion_date":"2030-03-30","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07540572","publication_url":"https://clinicaltrials.gov/study/NCT07540572","title":"An Open Label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of IDE574 as Monotherapy in Locally Advanced or Metastatic Solid Tumors and as Combination Therapy With Fulvestrant in Locally Advanced or Metastatic ER+, HER2- Breast Cancer","has_exemption":false,"start_date":"2026-03-17","completion_date":"2030-03-30","has_results":false,"results_due":false,"sponsor_name":"IDEAYA Biosciences","sponsor_slug":"ideaya-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02050113","publication_url":"https://clinicaltrials.gov/study/NCT02050113","title":"Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices","has_exemption":false,"start_date":"2014-03-31","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Andres Schanzer","sponsor_slug":"andres-schanzer","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03048201","publication_url":"https://clinicaltrials.gov/study/NCT03048201","title":"Post-market Registry Study on the Physica System Total Knee Replacement","has_exemption":false,"start_date":"2017-03-24","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Limacorporate S.p.a","sponsor_slug":"limacorporate-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03674372","publication_url":"https://clinicaltrials.gov/study/NCT03674372","title":"Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Right and Left Congenital Diaphragmatic Hernia (CDH)","has_exemption":false,"start_date":"2018-11-16","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04683250","publication_url":"https://clinicaltrials.gov/study/NCT04683250","title":"Phase I/II Study of the Selective RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities","has_exemption":false,"start_date":"2020-12-16","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Taiho Pharmaceutical Co., Ltd.","sponsor_slug":"taiho-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05286801","publication_url":"https://clinicaltrials.gov/study/NCT05286801","title":"A Phase 1/2 Study of Tiragolumab (NSC# 827799) and Atezolizumab (NSC# 783608) in Patients With Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors","has_exemption":false,"start_date":"2022-11-17","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05259527","publication_url":"https://clinicaltrials.gov/study/NCT05259527","title":"Impact of Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy","has_exemption":false,"start_date":"2022-12-19","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06153173","publication_url":"https://clinicaltrials.gov/study/NCT06153173","title":"A Phase II Trial of the MEK Inhibitor Mirdametinib in Histiocytic Disorders","has_exemption":false,"start_date":"2024-02-05","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06274528","publication_url":"https://clinicaltrials.gov/study/NCT06274528","title":"Effect of a Dual Orexin Receptor Antagonist on CSF Alzheimer's Disease Biomarkers","has_exemption":false,"start_date":"2024-03-11","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06013865","publication_url":"https://clinicaltrials.gov/study/NCT06013865","title":"An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)","has_exemption":false,"start_date":"2024-04-05","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06424756","publication_url":"https://clinicaltrials.gov/study/NCT06424756","title":"Role of Mitochondria-derived Oxidative Stress on Microvascular Endothelial Function in Healthy Non-Hispanic Black and White Adults","has_exemption":false,"start_date":"2024-07-01","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Georgia","sponsor_slug":"university-of-georgia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06802315","publication_url":"https://clinicaltrials.gov/study/NCT06802315","title":"A Phase II Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Myeloablative Fludarabine/Busulfan and Post-Transplant Cyclophosphamide (PTCY) for Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk AML, CML, and MDS","has_exemption":false,"start_date":"2025-02-04","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06926790","publication_url":"https://clinicaltrials.gov/study/NCT06926790","title":"Neoadjuvant Nivolumab Plus Ipilimumab in Resectable Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2025-02-17","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"The First Affiliated Hospital of Guangzhou Medical University","sponsor_slug":"the-first-affiliated-hospital-of-guangzhou-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06805305","publication_url":"https://clinicaltrials.gov/study/NCT06805305","title":"Randomized Study of DOC1021 Dendritic Cell Immunotherapy in Combination With Standard of Care for Newly Diagnosed Adult Glioblastoma","has_exemption":false,"start_date":"2025-03-17","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Diakonos Oncology Corporation","sponsor_slug":"diakonos-oncology-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06847269","publication_url":"https://clinicaltrials.gov/study/NCT06847269","title":"CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia: An Investigation of Lymphodepleting Chemotherapy Pharmacokinetics","has_exemption":false,"start_date":"2025-05-21","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07076342","publication_url":"https://clinicaltrials.gov/study/NCT07076342","title":"Mechanistic Clinical Trial Evaluating the Role of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5) in the Antidepressant Mechanism of Cognitive Behavioral Therapy for Insomnia (CBT-I)","has_exemption":false,"start_date":"2025-08-01","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Stony Brook University","sponsor_slug":"stony-brook-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07193511","publication_url":"https://clinicaltrials.gov/study/NCT07193511","title":"A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-103, a Nectin4/Trop2 ADC, as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors","has_exemption":false,"start_date":"2025-10-02","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Avenzo Therapeutics, Inc.","sponsor_slug":"avenzo-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06937866","publication_url":"https://clinicaltrials.gov/study/NCT06937866","title":"Maintenance Zanzalintinib With Oral Etoposide Following High-dose Chemotherapy in Patients With Relapsed Metastatic Germ-cell Tumor","has_exemption":false,"start_date":"2025-11-12","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07108270","publication_url":"https://clinicaltrials.gov/study/NCT07108270","title":"A Phase 2, Multicenter, Open-label, Single Arm Study of Dostarlimab Plus Carboplatin-paclitaxel Followed by Dostarlimab Monotherapy in Participants With dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer in China (China RUBY)","has_exemption":false,"start_date":"2025-11-27","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07159841","publication_url":"https://clinicaltrials.gov/study/NCT07159841","title":"A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants With Congenital Adrenal Hyperplasia Including a Long-Term Extension","has_exemption":false,"start_date":"2026-01-22","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Crinetics Pharmaceuticals Inc.","sponsor_slug":"crinetics-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07286006","publication_url":"https://clinicaltrials.gov/study/NCT07286006","title":"A Long-Term Extension Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Patients With Graves' Disease","has_exemption":false,"start_date":"2026-01-26","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Immunovant Sciences GmbH","sponsor_slug":"immunovant-sciences-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284758","publication_url":"https://clinicaltrials.gov/study/NCT07284758","title":"A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma","has_exemption":false,"start_date":"2026-02-18","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"C4 Therapeutics, Inc.","sponsor_slug":"c4-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07464886","publication_url":"https://clinicaltrials.gov/study/NCT07464886","title":"Prefrontal Glutamatergic Modulation by N-acetylcysteine and Mindfulness-based Cognitive Therapy for Mild Depression in Youth","has_exemption":false,"start_date":"2026-02-26","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07432295","publication_url":"https://clinicaltrials.gov/study/NCT07432295","title":"A Randomized, Multicenter, Open-Label, Phase 2 Study of Givastomig (TJ033721) in Combination With Nivolumab and Chemotherapy Versus Nivolumab and Chemotherapy in Participants With Previously Untreated CLDN18.2 Positive and PD-1L Positive Locally Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Junction Adenocarcinoma","has_exemption":false,"start_date":"2026-02-28","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"I-Mab Biopharma US Limited","sponsor_slug":"i-mab-biopharma-us-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281027","publication_url":"https://clinicaltrials.gov/study/NCT07281027","title":"Comparing the Effects of Anakinra and Tocilizumab on Outcomes in Patients With New-Onset Refractory Status Epilepticus","has_exemption":false,"start_date":"2026-03-01","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07470606","publication_url":"https://clinicaltrials.gov/study/NCT07470606","title":"Memory RT: Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain","has_exemption":false,"start_date":"2026-03-31","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07158242","publication_url":"https://clinicaltrials.gov/study/NCT07158242","title":"A Phase III Randomized Double-Blind Multi-Center Treat-Through Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Children Aged 2 - 17 Years With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2026-04-15","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07346144","publication_url":"https://clinicaltrials.gov/study/NCT07346144","title":"A Phase I/II Study of an AAV-1 Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma","has_exemption":false,"start_date":"2026-04-21","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Trogenix ltd","sponsor_slug":"trogenix-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566156","publication_url":"https://clinicaltrials.gov/study/NCT07566156","title":"A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO EVALUATE ENFORTUMAB VEDOTIN IN COMBINATION WITH PEMBROLIZUMAB IN ADULT PARTICIPANTS WITH MUSCLE-INVASIVE BLADDER CANCER WHO ARE INELIGIBLE FOR OR HAVE ELECTED NOT TO UNDERGO CYSTECTOMY","has_exemption":false,"start_date":"2026-05-11","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07262060","publication_url":"https://clinicaltrials.gov/study/NCT07262060","title":"Optimizing Caffeine Therapy for Hypoxia in Preterm Neonates: A Randomized Trial Assessing Efficacy, Acute Kidney and Brain Injury, Safety, and Pharmacokinetics","has_exemption":false,"start_date":"2026-05-31","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07448974","publication_url":"https://clinicaltrials.gov/study/NCT07448974","title":"Vitamin D and Type 2 Diabetes, Treat-To-Target","has_exemption":false,"start_date":"2026-05-31","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"Tufts Medical Center","sponsor_slug":"tufts-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07187466","publication_url":"https://clinicaltrials.gov/study/NCT07187466","title":"Sequential Multiple Assignment Randomized Trial to Treat Urinary Symptoms in Parkinson Disease","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-03-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04042402","publication_url":"https://clinicaltrials.gov/study/NCT04042402","title":"An Open-Label Roll-Over Study to Evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injection (Subcutaneous Use) in Patients With Primary Hyperoxaluria","has_exemption":false,"start_date":"2019-07-09","completion_date":"2030-04-01","has_results":false,"results_due":false,"sponsor_name":"Dicerna Pharmaceuticals, Inc., a Novo Nordisk company","sponsor_slug":"dicerna-pharmaceuticals-inc-a-novo-nordisk-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07112287","publication_url":"https://clinicaltrials.gov/study/NCT07112287","title":"MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies","has_exemption":false,"start_date":"2025-11-10","completion_date":"2030-04-01","has_results":false,"results_due":false,"sponsor_name":"Christopher Reilly","sponsor_slug":"christopher-reilly","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07489976","publication_url":"https://clinicaltrials.gov/study/NCT07489976","title":"Leveraging Immunotherapy For Tumor Downstaging to Milan Criteria in Patients With Hepatocellular Carcinoma","has_exemption":false,"start_date":"2026-04-01","completion_date":"2030-04-01","has_results":false,"results_due":false,"sponsor_name":"Ju Dong Yang","sponsor_slug":"ju-dong-yang","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07029776","publication_url":"https://clinicaltrials.gov/study/NCT07029776","title":"A Phase 2 Study Exploring the Use of Bispecific Antibodies to Improve Progression Free Survival in Patients With High-Risk Newly Diagnosed Multiple Myeloma (MMulti-Immune HR)","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05972629","publication_url":"https://clinicaltrials.gov/study/NCT05972629","title":"A Phase 1/Phase 2, Open-label, Dose-escalation, and Dose Expansion Study to Evaluate the Safety, Tolerability, and Efficacy of SAR444836, an Adeno-associated Viral Vector-mediated Gene Transfer of Human Phenylalanine Hydroxylase, in Adult Participants With Phenylketonuria","has_exemption":false,"start_date":"2023-08-07","completion_date":"2030-04-02","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07326709","publication_url":"https://clinicaltrials.gov/study/NCT07326709","title":"A Randomized, Placebo-controlled, Double-blind Phase 3 Study to Evaluate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease","has_exemption":false,"start_date":"2026-03-24","completion_date":"2030-04-02","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06133972","publication_url":"https://clinicaltrials.gov/study/NCT06133972","title":"A Randomized, Double-blind, Placebo-controlled Extension Study to Assess the Long-term Safety and Tolerability of Ianalumab in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE Extension)","has_exemption":false,"start_date":"2024-05-21","completion_date":"2030-04-08","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03718403","publication_url":"https://clinicaltrials.gov/study/NCT03718403","title":"Effect of Theophylline in Pseudohypoparathyroidism","has_exemption":false,"start_date":"2019-11-11","completion_date":"2030-04-10","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05582993","publication_url":"https://clinicaltrials.gov/study/NCT05582993","title":"A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis With Vonicog Alfa (rVWF) in Children Diagnosed With Severe Von Willebrand Disease","has_exemption":false,"start_date":"2024-11-06","completion_date":"2030-04-11","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06632977","publication_url":"https://clinicaltrials.gov/study/NCT06632977","title":"PREcision DIagnostics in Prostate Cancer Treatment (PREDICT)","has_exemption":false,"start_date":"2025-02-06","completion_date":"2030-04-11","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07061574","publication_url":"https://clinicaltrials.gov/study/NCT07061574","title":"A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes","has_exemption":false,"start_date":"2026-03-10","completion_date":"2030-04-15","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06397703","publication_url":"https://clinicaltrials.gov/study/NCT06397703","title":"A Phase II Prospective 2-Arm Cohort Interventional Trial Utilizing Ultra-Hypofractionated SBRT With or Without Short Course Androgen Deprivation Therapy For Unfavorable Intermediate Risk Prostate Cancer","has_exemption":false,"start_date":"2024-04-16","completion_date":"2030-04-16","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06686394","publication_url":"https://clinicaltrials.gov/study/NCT06686394","title":"HERTHENA-Breast-01: A Phase 1b/2, Multicenter, Open-label, Dose-Finding Study to Evaluate the Safety and Antitumor Activity of Patritumab Deruxtecan in Participants With HER2 Positive Unresectable Locally Advanced Breast Cancer or Metastatic Breast Cancer","has_exemption":false,"start_date":"2025-02-26","completion_date":"2030-04-18","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06117774","publication_url":"https://clinicaltrials.gov/study/NCT06117774","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Have Not Progressed Following Concurrent Chemoradiation Therapy","has_exemption":false,"start_date":"2024-02-20","completion_date":"2030-04-20","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07153497","publication_url":"https://clinicaltrials.gov/study/NCT07153497","title":"A Randomized Phase 2 Trial of Olutasidenib-Based Therapies in Patients With Newly Diagnosed IDH1-Mutant Myeloid Malignancies: A MyeloMATCH Substudy","has_exemption":false,"start_date":"2026-05-27","completion_date":"2030-04-26","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566377","publication_url":"https://clinicaltrials.gov/study/NCT07566377","title":"Cord Blood Transplantation in Children and Young Adults With Hematologic Malignancies","has_exemption":false,"start_date":"2026-04-28","completion_date":"2030-04-28","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03547973","publication_url":"https://clinicaltrials.gov/study/NCT03547973","title":"A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer","has_exemption":false,"start_date":"2018-08-13","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04806854","publication_url":"https://clinicaltrials.gov/study/NCT04806854","title":"A Single-Center, Randomized, Open-Label, Parallel Arm Study of Daily Oral LUM-201 in Naive-to-Treatment, Prepubertal Children With Idiopathic Pediatric Growth Hormone Deficiency (PGHD)","has_exemption":false,"start_date":"2021-07-14","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Lumos Pharma","sponsor_slug":"lumos-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06012240","publication_url":"https://clinicaltrials.gov/study/NCT06012240","title":"A Phase 3 Randomized, Placebo-controlled, Double-blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Severe Alopecia Areata","has_exemption":false,"start_date":"2023-10-11","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05919108","publication_url":"https://clinicaltrials.gov/study/NCT05919108","title":"Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers","has_exemption":false,"start_date":"2024-05-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt-Ingram Cancer Center","sponsor_slug":"vanderbilt-ingram-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06322108","publication_url":"https://clinicaltrials.gov/study/NCT06322108","title":"Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)","has_exemption":false,"start_date":"2024-06-13","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Immune Oncology Research Institute","sponsor_slug":"immune-oncology-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06721689","publication_url":"https://clinicaltrials.gov/study/NCT06721689","title":"A Phase 1/2 Clinical Trial of the Novel Topoisomerase I Inhibitor PEEL-224 as a Single Agent and in Combination With Vincristine and Temozolomide in Children With Refractory, Progressive or Relapsed Solid Tumors","has_exemption":false,"start_date":"2025-03-23","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Theodore Laetsch","sponsor_slug":"theodore-laetsch","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06861920","publication_url":"https://clinicaltrials.gov/study/NCT06861920","title":"Targeting Interindividual Variability in NSAID Responses to Mitigate Chronic Pelvic Pain Risk in Dysmenorrhea (NSAID HEAL)","has_exemption":false,"start_date":"2025-04-07","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Endeavor Health","sponsor_slug":"endeavor-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06884423","publication_url":"https://clinicaltrials.gov/study/NCT06884423","title":"Infant Survival and Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial","has_exemption":false,"start_date":"2025-04-07","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Holly L Hedrick, MD","sponsor_slug":"holly-l-hedrick-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06892678","publication_url":"https://clinicaltrials.gov/study/NCT06892678","title":"DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma","has_exemption":false,"start_date":"2025-04-07","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06702033","publication_url":"https://clinicaltrials.gov/study/NCT06702033","title":"Phase II Trial of Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: \"The Minimalist Trial-2 (MINT-2)\"","has_exemption":false,"start_date":"2025-04-10","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06946576","publication_url":"https://clinicaltrials.gov/study/NCT06946576","title":"Infant Survival and Long-term Outcomes Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial","has_exemption":false,"start_date":"2025-09-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07231497","publication_url":"https://clinicaltrials.gov/study/NCT07231497","title":"Cognitive Strategies in Early Psychosis 1","has_exemption":false,"start_date":"2025-10-31","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284589","publication_url":"https://clinicaltrials.gov/study/NCT07284589","title":"Evaluation of Ultralow Dose PET Imaging for Detecting SSTR2 Radiotracer Uptake","has_exemption":false,"start_date":"2025-12-11","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Akiva Mintz","sponsor_slug":"akiva-mintz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06666348","publication_url":"https://clinicaltrials.gov/study/NCT06666348","title":"A Phase 1/2 Study of Mirdametinib and Vinblastine for Newly Diagnosed or Previously Untreated Patients With Pediatric Low-grade Glioma and Activation of the MAPK Pathway","has_exemption":false,"start_date":"2026-01-12","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"St. Justine's Hospital","sponsor_slug":"st-justines-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07469384","publication_url":"https://clinicaltrials.gov/study/NCT07469384","title":"Sensory Contributions to Third Visual Pathway Dysfunction in Schizophrenia: Correlation and Causation","has_exemption":false,"start_date":"2026-02-01","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Nathan Kline Institute for Psychiatric Research","sponsor_slug":"nathan-kline-institute-for-psychiatric-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07126158","publication_url":"https://clinicaltrials.gov/study/NCT07126158","title":"Phase II Study of Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2026-04-10","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05763693","publication_url":"https://clinicaltrials.gov/study/NCT05763693","title":"Vitality in Infants Via Azithromycin for Neonates Trial","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218575","publication_url":"https://clinicaltrials.gov/study/NCT07218575","title":"A Randomized, Placebo Controlled Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07191717","publication_url":"https://clinicaltrials.gov/study/NCT07191717","title":"Phase II Minimal Residual Disease Study of Selective Estrogen Receptor Degrader Imlunestrant With Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Abemaciclib in Patients With ER+ Breast Cancer (MIRI)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07475286","publication_url":"https://clinicaltrials.gov/study/NCT07475286","title":"A Phase II Single Arm Study of Combined Systemic and Intraperitoneal Chemotherapy for Synchronous Gastric and/or Gastroesophageal Peritoneal Carcinomatosis","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Mohammad Haroon Asif Choudry","sponsor_slug":"mohammad-haroon-asif-choudry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07571161","publication_url":"https://clinicaltrials.gov/study/NCT07571161","title":"A Study of Donanemab Versus Placebo in Chinese Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07263022","publication_url":"https://clinicaltrials.gov/study/NCT07263022","title":"Cognitive Strategies in Early Psychosis 2","has_exemption":false,"start_date":"2026-05-11","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07212998","publication_url":"https://clinicaltrials.gov/study/NCT07212998","title":"Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial","has_exemption":false,"start_date":"2026-06-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Jason Sperry","sponsor_slug":"jason-sperry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07421518","publication_url":"https://clinicaltrials.gov/study/NCT07421518","title":"Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT2 Inhibitors","has_exemption":false,"start_date":"2026-06-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"AdventHealth Translational Research Institute","sponsor_slug":"adventhealth-translational-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07050862","publication_url":"https://clinicaltrials.gov/study/NCT07050862","title":"Circuity-guided Repetitive Transcranial Magnetic Stimulation (rTMS) for Tobacco Use in Veterans: A Comparison of Insula-rTMS and Prefrontal-rTMS","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05684159","publication_url":"https://clinicaltrials.gov/study/NCT05684159","title":"A Phase II, Open-Label Study of NM8074 in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)","has_exemption":false,"start_date":"2027-11-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"NovelMed Therapeutics","sponsor_slug":"novelmed-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03346694","publication_url":"https://clinicaltrials.gov/study/NCT03346694","title":"Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing","has_exemption":false,"start_date":"2018-05-01","completion_date":"2030-05-01","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05285891","publication_url":"https://clinicaltrials.gov/study/NCT05285891","title":"Randomized, Blinded Discontinuation Trial of Ocrelizumab in Early Relapsing Multiple Sclerosis (AMS05)","has_exemption":false,"start_date":"2023-01-12","completion_date":"2030-05-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07118839","publication_url":"https://clinicaltrials.gov/study/NCT07118839","title":"MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-04-15","completion_date":"2030-05-01","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07512336","publication_url":"https://clinicaltrials.gov/study/NCT07512336","title":"A Randomized Intra-Patient Controlled Trial of MagnetOs™ Putty vs Autograft in Instrumented Posterolateral Spinal Fusion in Idiopathic Scoliosis Patients","has_exemption":false,"start_date":"2026-05-01","completion_date":"2030-05-01","has_results":false,"results_due":false,"sponsor_name":"UMC Utrecht","sponsor_slug":"umc-utrecht","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06585410","publication_url":"https://clinicaltrials.gov/study/NCT06585410","title":"A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC)","has_exemption":false,"start_date":"2025-01-02","completion_date":"2030-05-03","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05692180","publication_url":"https://clinicaltrials.gov/study/NCT05692180","title":"Efficacy and Safety of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)","has_exemption":false,"start_date":"2023-04-05","completion_date":"2030-05-05","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06663722","publication_url":"https://clinicaltrials.gov/study/NCT06663722","title":"A Phase II b Study of Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease","has_exemption":false,"start_date":"2025-05-05","completion_date":"2030-05-05","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222189","publication_url":"https://clinicaltrials.gov/study/NCT07222189","title":"A Multinational, Multicenter Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Adults With Crohn's Disease or Ulcerative Colitis","has_exemption":false,"start_date":"2026-05-12","completion_date":"2030-05-10","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223190","publication_url":"https://clinicaltrials.gov/study/NCT07223190","title":"A Phase 3, Open-label, Randomized, Controlled Trial of Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With Philadelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic Leukaemia","has_exemption":false,"start_date":"2026-06-11","completion_date":"2030-05-10","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06841354","publication_url":"https://clinicaltrials.gov/study/NCT06841354","title":"A Phase 3, Randomized, Open-label Study Comparing Efficacy and Safety of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as a Monotherapy and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With Previously Untreated Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Expressing PD-L1 at CPS Less Than 10 (TroFuse-011)","has_exemption":false,"start_date":"2025-03-16","completion_date":"2030-05-18","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07447817","publication_url":"https://clinicaltrials.gov/study/NCT07447817","title":"Investigator-Initiated, Open-Label, Phase II Trial of Selinexor in Combination With Pacritinib in Patients With Myelofibrosis Who Are JAK Inhibitor-Naïve and Have Cytopenias (ILLUMINATE)","has_exemption":false,"start_date":"2026-05-04","completion_date":"2030-05-24","has_results":false,"results_due":false,"sponsor_name":"John Mascarenhas","sponsor_slug":"john-mascarenhas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06932757","publication_url":"https://clinicaltrials.gov/study/NCT06932757","title":"Phase 2 Trial of Adjuvant Quisinostat in High-Risk Uveal Melanoma","has_exemption":false,"start_date":"2025-05-27","completion_date":"2030-05-27","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05061550","publication_url":"https://clinicaltrials.gov/study/NCT05061550","title":"A Phase II, Open-label, Multicentre, Randomised Study of Neoadjuvant and Adjuvant Treatment in Patients With Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer (NeoCOAST-2)","has_exemption":false,"start_date":"2022-04-14","completion_date":"2030-05-28","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07052903","publication_url":"https://clinicaltrials.gov/study/NCT07052903","title":"TRITON-CM: A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)","has_exemption":false,"start_date":"2025-07-02","completion_date":"2030-05-28","has_results":false,"results_due":false,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03701334","publication_url":"https://clinicaltrials.gov/study/NCT03701334","title":"A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)","has_exemption":false,"start_date":"2018-12-07","completion_date":"2030-05-29","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05775367","publication_url":"https://clinicaltrials.gov/study/NCT05775367","title":"Cochlear Implantation in Infants and Toddlers With Single-Sided Deafness","has_exemption":false,"start_date":"2023-07-07","completion_date":"2030-05-30","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07565194","publication_url":"https://clinicaltrials.gov/study/NCT07565194","title":"Arousal-related Memory of Movie Clips During Individualized IPS Targeting fMRI and TBS.","has_exemption":false,"start_date":"2026-06-01","completion_date":"2030-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07565207","publication_url":"https://clinicaltrials.gov/study/NCT07565207","title":"The Effect of Within-network aiTBS on Cortical Excitability, Intrinsic Oscillatory Bands, and Behavioral Task Performance","has_exemption":false,"start_date":"2026-06-01","completion_date":"2030-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02115295","publication_url":"https://clinicaltrials.gov/study/NCT02115295","title":"Phase II Study of Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With AML, HR MDS, or Myeloid Blast Phase of CML","has_exemption":false,"start_date":"2014-05-19","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02310399","publication_url":"https://clinicaltrials.gov/study/NCT02310399","title":"Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves","has_exemption":false,"start_date":"2014-05-31","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03394365","publication_url":"https://clinicaltrials.gov/study/NCT03394365","title":"Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy","has_exemption":false,"start_date":"2017-12-29","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Pierre Fabre Medicament","sponsor_slug":"pierre-fabre-medicament","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03618186","publication_url":"https://clinicaltrials.gov/study/NCT03618186","title":"Neuroimaging Study","has_exemption":false,"start_date":"2018-11-26","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null}]}